Artigo
Phytate technetium-99m versus dextran 500 technetium-99m in the sentinel lymph node biopsy
Fecha
2006-02-01Registro en:
Acta Radiologica. Abingdon: Taylor & Francis Ltd, v. 47, n. 1, p. 65-70, 2006.
0284-1851
10.1080/02841850500406803
WOS:000235289600012
Autor
Paiva, G. R.
Filho, RSO
Ferreira, L. M.
Wagner, J.
Nogueira, WSA
Novo, N. F.
Juliano, Y.
Rocha, JLBS
Institución
Resumen
Purpose: To study which of the two most used radiopharmaceutical drugs for the sentinel lymph node (SLN) biopsy procedure (dextran 500 Tc-99m and phytate Tc-99m) best defines the SLN and migrates less to other lymph nodes.Material and Methods: Thirty-two rats, separated into two groups, underwent lymphoscintigraphy examination with either dextran or phytate followed by sentinel (popliteal), lumbar, and inguinal lymph node biopsy. Radiation was detected with a gamma probe.Results: the statistical study indicated count rates significantly higher in the SLN than in the other basins for both the dextran (P < 0.01) and phytate groups (P < 0.001). There was no statistically significant difference concerning SLN absorption in either group (P=0.2981). in the dextran group, migration occurred to 1.5 lymphatic basins with counting higher than 10% of that found in the SLN versus 0.8 in the phytate group (P=0.0023). Migration was thus higher in the dextran group (P=0.0207).Conclusion: There was no statistically significant difference between dextran and phytate in the SLN identification, but the phytate migrated to fewer lymphatic basins beyond the SLN and with less intensity.